CIK: 1225198 - Address: C/o Intra-Cellular Therapies, Inc., 430 East 29Th Street, New York, NY 10016
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
6/21/24 18:00
6/18/24
ITCIIntra-Cellular Therapies, Inc.DEHealthDrugPharmaceutical PreparationsVan Nostrand Robert LNYDS.d-1,51875.910-20-6710D
2/28/24 19:41
2/27/24
ITCIIntra-Cellular Therapies, Inc.DEHealthDrugPharmaceutical PreparationsVan Nostrand Robert LNYDS.d-1,45972.930-20-6810D
4/19/23 18:00
4/17/23
ITCIIntra-Cellular Therapies, Inc.DEHealthDrugPharmaceutical PreparationsVan Nostrand Robert LNYDS.d-63063.000-10-529D
8/12/22 18:09
8/11/22
ITCIIntra-Cellular Therapies, Inc.DEHealthDrugPharmaceutical PreparationsVan Nostrand Robert LNYDS.d-1,71457.130-30-779D
5/3/05 16:56
5/2/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-5947.440-1-205D
4/19/05 16:56
4/15/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-5050.000-1-175D
4/7/05 10:09
4/6/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-5645.000-1-205D
3/3/05 16:37
3/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-12153.980-2-315D
2/3/05 16:17
2/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-14765.120-2-315D
1/5/05 17:15
1/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-40773.970-6-535D
12/3/04 16:47
12/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-13348.320-3-365D
11/2/04 19:44
11/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-17764.340-3-375D
10/5/04 14:43
10/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-16861.090-3-375D
9/2/04 17:11
9/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-16359.150-3-375D
8/4/04 16:48
8/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-16058.170-3-375D
7/2/04 16:20
7/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-19269.880-3-375D
6/3/04 17:48
6/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-22381.270-3-375D
5/5/04 17:25
5/3/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-20273.380-3-375D
4/27/04 16:58
4/26/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-10181.160-1-215D
4/21/04 13:09
4/20/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-3340.000-1-155D
4/2/04 16:36
4/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.d-2638.270-1-125D
1/23/04 12:13
1/21/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS.m-14335.660-4-465D
1/6/04 10:15
1/2/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS-13132.650-4-465D
12/22/03 18:26
12/22/03
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS-4830.210-2-255D
10/3/03 16:07
10/1/03
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticVan Nostrand Robert LNYOVP,CFOS-12932.350-4-534D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact